# Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain

> **NCT05969392** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Gelscom SAS** · enrollment: 60 (estimated)

## Conditions studied

- Pain, Cervical
- Discogenic Pain

## Interventions

- **DEVICE:** Intradiscal Gelified Ethanol (Discogel)

## Key facts

- **NCT ID:** NCT05969392
- **Lead sponsor:** Gelscom SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04
- **Primary completion:** 2025-07
- **Final completion:** 2026-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05969392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05969392, "Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05969392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*